Advertisement
BRKR vs TMO
Which Stock Would AI Choose? Bruker Corporation (BRKR) vs. Thermo Fisher Scientific Inc. (TMO) Stock Comparison
Key Takeaways
- Bruker Corporation (BRKR) has delivered stronger year-to-date returns compared to Thermo Fisher Scientific Inc. (TMO), with approximately 25% gains versus roughly 8% for TMO amid differing market responses to sector conditions.
- Both companies operate in the life sciences and analytical instruments space, but BRKR focuses on specialized scientific tools while TMO offers a broader portfolio including diagnostics and biopharma services.
- Recent market activity shows BRKR benefiting from analyst upgrades and acquisition activity, contributing to momentum near its 52-week highs, whereas TMO trades in a range ahead of its Q2 earnings release.
- TMO maintains a significantly larger market capitalization, providing greater scale and stability, while BRKR exhibits higher percentage volatility and growth potential in niche areas.
- Sector exposure to life sciences and materials research links both stocks, though TMO faces noted softness in academic and government demand in certain regions.
- Relative performance highlights trade-offs between BRKR's recent outperformance and TMO's established position in a more diversified business model.
Introduction
Bruker Corporation (BRKR) and Thermo Fisher Scientific Inc. (TMO) represent two prominent players in the scientific instruments and life sciences sector, making them relevant for comparison among investors and traders seeking exposure to analytical technology and research tools. This analysis examines their business models, recent stock behavior, and market positioning to assist those evaluating relative opportunities in the current environment. Participants interested in sector-specific dynamics, growth drivers, and performance contrasts may find this stock comparison useful for informed decision-making.
BRKR Overview and Recent Performance
Bruker Corporation (BRKR) develops and manufactures scientific instruments and solutions for life sciences, materials research, and industrial applications. In recent weeks, the stock has shown notable strength, advancing approximately 25% year-to-date and trading near levels close to its 52-week high amid positive analyst commentary and corporate developments. Recent market activity reflects gains following earnings beats in prior quarters and strategic moves such as acquisitions that enhance its capabilities in areas like metagenomic analysis. Sentiment has been supported by optimism around new product launches and flexibility for potential deals, contributing to outperformance relative to broader benchmarks in the period.
TMO Overview and Recent Performance
Thermo Fisher Scientific Inc. (TMO) provides a wide array of scientific instruments, reagents, consumables, and services primarily for life sciences, diagnostics, and biopharma customers. In recent market activity, the stock has traded in a defined range around the $530-$543 level, with year-to-date returns near 8% as the company prepares for its Q2 earnings report. Developments include ongoing management of demand softness in academic and government channels alongside strength in certain biopharma segments. Broader sector rotation and upcoming results have influenced positioning, with the larger enterprise maintaining steady operations despite noted challenges in specific end markets.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available on the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance metrics tailored to current market conditions. Only those demonstrating the strongest suitability and results earn placement in the trending section, offering users access to diverse options with ranges of returns, drawdowns, and win rates depending on the specific bot. All AI trading bots feature distinct trading styles, risk parameters, and sets of tickers they target. Review the full selection on the Trending AI Robots page to explore available configurations.
Head-to-Head Comparison
Bruker Corporation (BRKR) and Thermo Fisher Scientific Inc. (TMO) differ in scale and focus within the life sciences instruments sector. BRKR emphasizes specialized analytical tools with recent momentum from targeted acquisitions and product innovations, while TMO delivers a broader portfolio spanning diagnostics, lab products, and biopharma services with greater overall market capitalization. Recent performance shows BRKR achieving higher percentage returns year-to-date alongside elevated volatility, contrasting with TMO’s more measured movements ahead of earnings. Growth drivers for BRKR include expansion in semiconductor and overseas orders, whereas TMO contends with variable demand in academic segments offset by collaborations and instrument launches. Risk factors involve BRKR’s smaller size potentially amplifying swings, while TMO’s exposure includes regional demand pressures and competitive dynamics in a larger enterprise. Market sentiment has favored BRKR’s recent catalysts relative to TMO’s positioning in a stable but challenged sector environment.
Tickeron AI Verdict
Based on observable factors including trend consistency and recent momentum, Tickeron’s AI would currently assign a higher probability of favorable positioning to Bruker Corporation (BRKR) over Thermo Fisher Scientific Inc. (TMO). This assessment draws from BRKR’s stronger relative returns, proximity to recent highs, and supportive developments such as analyst upgrades and acquisitions that align with sustained upward movement. TMO demonstrates stability through its scale but shows more tempered performance amid upcoming earnings and sector headwinds. The verdict remains probabilistic and reflects current data patterns rather than guarantees of future outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a StrongBuy and TMO is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BRKR’s FA Score shows that 1 FA rating(s) are green whileTMO’s FA Score has 1 green FA rating(s).
- BRKR’s FA Score: 1 green, 4 red.
- TMO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BRKR’s TA Score shows that 3 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).
- BRKR’s TA Score: 3 bullish, 2 bearish.
- TMO’s TA Score: 6 bullish, 4 bearish.
Price Growth
BRKR (@Medical/Nursing Services) experienced а +3.81% price change this week, while TMO (@Medical Specialties) price change was +6.72% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.78%. For the same industry, the average monthly price growth was -7.49%, and the average quarterly price growth was -21.89%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.55%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +1.12%.
Reported Earning Dates
BRKR is expected to report earnings on Aug 05, 2026.
TMO is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.78% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-1.55% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| BRKR | TMO | BRKR / TMO | |
| Capitalization | 9.2B | 211B | 4% |
| EBITDA | 306M | 11.7B | 3% |
| Gain YTD | 28.622 | -1.736 | -1,649% |
| P/E Ratio | 74.88 | 30.58 | 245% |
| Revenue | 3.46B | 45.2B | 8% |
| Total Cash | N/A | 1.12B | - |
| Total Debt | 1.67B | 43.2B | 4% |
BRKR | TMO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 77 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 80 | |
SMR RATING 1..100 | 92 | 62 | |
PRICE GROWTH RATING 1..100 | 36 | 40 | |
P/E GROWTH RATING 1..100 | 7 | 37 | |
SEASONALITY SCORE 1..100 | 85 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TMO's Valuation (12) in the Medical Specialties industry is somewhat better than the same rating for BRKR (50). This means that TMO’s stock grew somewhat faster than BRKR’s over the last 12 months.
TMO's Profit vs Risk Rating (80) in the Medical Specialties industry is in the same range as BRKR (100). This means that TMO’s stock grew similarly to BRKR’s over the last 12 months.
TMO's SMR Rating (62) in the Medical Specialties industry is in the same range as BRKR (92). This means that TMO’s stock grew similarly to BRKR’s over the last 12 months.
BRKR's Price Growth Rating (36) in the Medical Specialties industry is in the same range as TMO (40). This means that BRKR’s stock grew similarly to TMO’s over the last 12 months.
BRKR's P/E Growth Rating (7) in the Medical Specialties industry is in the same range as TMO (37). This means that BRKR’s stock grew similarly to TMO’s over the last 12 months.
| BRKR | TMO | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 72% | 2 days ago 59% |
| MACD ODDS (%) | N/A | 2 days ago 66% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 61% |
| Advances ODDS (%) | 24 days ago 69% | 3 days ago 61% |
| Declines ODDS (%) | 6 days ago 73% | 5 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 63% |
| Aroon ODDS (%) | N/A | 2 days ago 59% |
Advertisement